CLINICAL_TRIALS
trial_result
· 2021-04-09
Clinical Trial Update: Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia [Phase 1, Phase 2]
Summary
Clinical study on meplazumab (anti-CD147) for injection to treat COVID-19 completed Phase 1/2 trials.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tang-Du Hospital | Conditions: Coronavirus Disease 2019 (COVID-19) | Phase 1, Phase 2 | Status: COMPLETED